October 23, 2026 · Reproductive biology and endocrinology : RB&E · DOI: 10.1186/s12958-026-01592-3

Ovarian fibrosis in polyendocrine metabolic ovarian syndrome: emerging mechanisms and therapeutic implications.

Listen to this summary

This review asks whether ovarian fibrosis, marked by excessive extracellular matrix deposition and structural remodeling, is a central driver of reproductive decline in polyendocrine metabolic ovarian syndrome (PMOS). The authors synthesize how hyperandrogenemia, insulin resistance, and chronic low-grade inflammation contribute to fibrosis via pathways such as TGF-β/CTGF and mitochondrial exhaustion, and they review pharmacological, regenerative, and traditional Chinese medicine approaches. They conclude that the causal links between PMOS and fibrosis remain underexplored, and they propose anti-fibrotic strategies as a high-potential therapeutic frontier.

Mengqing Gu, Jing Wang, Zhonghong Zeng, Yang Yu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play